🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Smita S. Joshi

Memorial Sloan Kettering Cancer Center

ORCID: 0000-0001-5272-2855

MedicineBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 3 papers. Top paper: “First-line regorafenib with nivolumab and chemotherapy in advanced oesophageal, gastric, or gastro-oesophageal junction cancer in the USA: a single-arm, single-centre, phase 2 trial”.

First-line regorafenib with nivolumab and chemotherapy in advanced oesophageal, gastric, or gastro-oesophageal junction cancer in the USA: a single-arm, single-centre, phase 2 trial

The Lancet Oncology(2023)10.1016/s1470-2045(23)00358-3

N/A

1.5DataRank · unranked

45 citations

Ryan H. Moy, Darren Cowzer, Ronak Shah, Joanne F. Chou, Smita S. Joshi +25 more

Clinical and molecular characteristics of early-onset vs average-onset esophagogastric cancer

JNCI Journal of the National Cancer Institute(2023)10.1093/jnci/djad186

N/A

0.999DataRank · unranked

35 citations

Henry Walch, Steven B. Maron, Walid K. Chatila, Yelena Kemel, Anna Maio +20 more

Phase 2 trial of pembrolizumab and olaparib (POLAR) maintenance for patients (pts) with metastatic pancreatic cancer (mPDAC): Two cohorts B non-core homologous recombination deficiency (HRD) and C exceptional response to platinum-therapy.

Journal of Clinical Oncology(2023)10.1200/jco.2023.41.16_suppl.4140

N/A

0.449DataRank · unranked

19 citations

Catherine O’Connor, Joanne F. Chou, Carly Schwartz, Anna M. Varghese, Mary Pat Larsen +15 more